Research & Development: Page 40
-
PharmaVoice Team/PharmaVoice
Transformation: Is the Industry Ready?
Although the pharma industry scored pretty low on a McKinsey scale of digital maturity, there is evidence that it is moving — perhaps only incrementally — toward a digital transformation that can streamline processes, generate collaboration, and coordinate data collection. The pharma sector, not ...
By PharmaVoice Team • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Regenerative Medicine: The Dawn of a New Age of Biology
Regenerative medicine could completely shake up the way diseases are treated. According to Reportlinker, the regenerative medicine market will reach an estimated $50.55 billion by 2025 thanks to the rapid growth of stem cell and gene therapy in developed markets. Scott Bruder, M.D., Ph.D., founde...
By Kim Ribbink • June 1, 2018 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Red Zone: Personalized Medicine Requires Personalized Measurement
CNS is the second largest area of pharmaceutical research, but the success rate has been low and approvals rare. In CNS drug development, it is common for investigational therapies to show promising effects in earlier trials, only to fail in the final stages of testing. Some of the reasons can be...
By Sofija Jovic • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
Understanding The Why Applying health psychology to deliver effective patient support As a health and clinical psychologist, I’ve spent the last ten years helping the healthcare industry address the self-management needs of patients living with long-term conditions. For the most part, this work h...
By Kate Perry • June 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Riding the AI Wave It would be hard to identify a hotter trend right now than artificial intelligence and machine learning — a trend 60 years in the making since John McCarthy coined the term AI while leading a Dartmouth Summer Research Project. Merriam-Webster defines AI as: a branch of computer...
By Taren Grom • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Upfront
Acorda Rallies Parkinson’s Community Acorda Therapeutics has launched the “Live Well. Do Tell.” initiative for the Parkinson’s disease community. Its goal is to encourage the community to improve conversations about Parkinson’s symptoms among the circle of care, including people with Parkinson’s,...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Researchers Develop Nanovesicle Method for Tumor Treatment Trend Watch: Technology boosts cancer care. According to a report by Penn State News, a team of scientists working at Penn State University, Second Affiliated Hospital of Southeast University, and Jiangsu Cancer Hospital & Jiangsu Ins...
By PharmaVoice Team • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator’s Corner
A Robotic Pill that Creates Oral Biologics Mir Imran, Chairman and CEO of Rani Therapeutics, talks about his company’s efforts to develop an injection-free, large-molecule delivery system. Biologics can only be administered through an injection, which can affect quality of life and patient compli...
By Mir Imran • May 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator’s Corner
Making Sense of Antisense Technology Brett Monia, Ph.D., Chief Operating Officer and Senior VP, Antisense Drug Discovery and Translational Medicine at Ionis Pharmaceuticals, talks about the company’s pipeline of antisense technology products. Antisense technology presents an opportunity to manipu...
By Brett Monia • March 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Blood Test Uses Machine Learning to Detect Multiple Early-Stage Cancers Trend Watch: Digital therapeutics, chips, patches, and machine learning enable better health outcomes. Johns Hopkins Kimmel Cancer Center researchers developed a single blood test — CancerSEEK, a unique noninvasive, multi-ana...
By PharmaVoice Team • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Addressing Diversity in Clinical Trials
Eliminating health disparities is an important public health issue, concerning all stakeholders. In oncology, for example, there are five cancers where disparities in adults have been identified: prostate cancer, breast cancer, colorectal cancer, hepatocellular carcinoma, and multiple myeloma. Fo...
By Denise Myshko • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Speak Out
From Discovery to Clinical Practice: A Brand Journey Requires Connected Thinking Today’s pharmaceutical brands are on the journey of a lifetime. And throughout this journey a brand takes on a burgeoning number of data sets, from pre-clinical trials all the way to real-world evidence and populat...
By Louisa Holland • March 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator’s Corner
Using Stem Cells to Treat Frailty Longeveron’s Chief Science Officer and Co-Founder Dr. Joshua Hare talks about the company’s cell-based therapies for age-related diseases. Breakthroughs in stem cell research could potentially lead to new treatment options for chronic diseases and injuries affec...
By Dr. Joshua Hare • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Draper R&D Uses Technology to Solve Unmet Healthcare Needs Trend Watch: Health technology is providing quicker, safer solutions for disease management and care. Draper, a nonprofit research and development company focused on advanced technological solutions, has designed the first pediatric h...
By PharmaVoice Team • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Last Word
Connecting Silos Through System Integration Monica Kennedy, Director of Regulatory Operations at Halozyme, discusses how technology can be leveraged to address inefficiencies in organizations. PV: What do think has led to operational silos and created inefficiencies? Kennedy: Technology is one f...
By Monica Kennedy • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Patient-Centric Trial Recruitment
Social media, mobile, and other technologies are making patient and physician outreach easier and more cost-effective and analytical tools are enhancing performance measurement, but patient recruitment for clinical trials continues to be a challenge. This is especially true for trials involving r...
By Denise Myshko • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Outsourcing: The Growth and Expansion of Outsourcing
Outsourcing in the pharma industry continues to increase, with many companies spending $50 million or more a year on outsourcing services. A survey from Outsourcing-Pharma.com found that 44% of pharmaceutical companies expected to outsource more business in 2017 than the previous year, and only 1...
By PharmaVoice Team • Feb. 1, 2018 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Tired of “innovation“ yet? No doubt that innovation is one of those “buzz-tion” words — transformation, collaboration, disruption — that some might deride as having been used so frequently that it has lost some of its inherent value as an action-based, momentum-driving movement. I say nay. Innova...
By Taren Grom • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Innovator’s Corner
Next-Generation Immuno-Oncology Stephen Isaacs, President and CEO of Aduro Biotech, talks about the company’s research of a small molecule that acts as a personalized “vaccine” against cancer. In recent years, we have seen the development and approval of immuno-oncology therapies that increase ...
By Stephen Isaacs • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
HealthTech
Apple Watch Expands Capabilities to improve health outcomes in cardiac, diabetes, depression Trend Watch: Apple Watch continues to revolutionize health data collection. Did you get an Apple Watch for the holidays? Lucky you, especially since several additional capabilities were unveiled at the en...
By PharmaVoice Team • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Pharma Innovation Labs
Innovative or collaborative partnerships in pharma are being touted by some as the “new normal.” Certainly, this is true of several pioneering pharmaceutical companies in the space, but authentic, independent or open-source collaborations are still a minority in the life-sciences ecosystem. The b...
By Robin Robinson • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Next-Generation Nanomedicines
The first generation of nanotechnology-based medicines, including nano-based drug delivery systems and nanovectors, improved the safe delivery of therapies that were once toxic. Nanoparticles have also proven to be especially good vehicles to effectively deliver cancer drugs, where many therapies...
By Denise Myshko • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Women’s Healthcare: Drug Development
With a U.S. healthcare market estimated at $2.8 trillion and purchasing either made or largely influenced by women, the “power of the purse” has never been stronger. According to Carolyn Buck Luce, executive-in-residence at the Center for Talent Innovation and an adjunct professor at Columbia Uni...
By Taren Grom • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Trend Tracking
In this special — 2018 Year in Preview — issue, PharmaVOICE’s thought leaders are tackling 10 trends that are expected to incite change in the year ahead. We will be looking at a variety of disparate topics that range from molecule to market in keeping with our publishing focus and philosophy: 20...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Real-World Outcomes
Real-word outcomes is not a new trend by any means, but it’s a market-changing model that is coming into its own and worthy of covering. That’s because the pharmaceutical market continues to shift to an outcomes-based reimbursement system, driven by payers’ need to rein in rising drug prices, adv...
By Denise Myshko • Nov. 20, 2017
Previous
